National Cancer Institute (NCI): all 3,554 studies

Page 31 of 36. Open to participants first (334), then studies with results posted, then the rest; newest registration first within each.

• Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00039117Phase 1
• Zoledronate and BMS-275291 in Treating Patients With Prostate CancerCompletedNCT00039104Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung CancerTerminatedNCT00039091Phase 1
• Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural MalignanciesCompletedNCT00037817Phase 1
• CC-5013 in Treating Patients With Recurrent GliomaCompletedNCT00036894Phase 1
• Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory LymphomaTerminatedNCT00036855Phase 1
• UCN-01 and Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00036777Phase 1
• BMS-247550 in Treating Patients With Stage IV MelanomaCompletedNCT00036764Phase 2
• Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00036751Phase 2
• Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research ProtocolsTerminatedNCT00035373
• Cause of Familial Testicular CancerCompletedNCT00034424
• Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckCompletedNCT00033618Phase 2
• Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder CancerCompletedNCT00033462Phase 2
• Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck CancerTerminatedNCT00033449Phase 1
• Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon CancerCompletedNCT00033358Phase 2
• Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00033332Phase 3
• CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's LymphomaCompletedNCT00033267Phase 2
• Radiation Therapy With or Without Thalidomide in Treating Patients With Brain MetastasesCompletedNCT00033254Phase 3
• Ketoconazole Plus Docetaxel to Treat Prostate CancerCompletedNCT00032825Phase 1
• Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected ChildrenCompletedNCT00032669Phase 1
• Cell Lines From High-Risk Breast TissueCompletedNCT00032201
• Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney CancerCompletedNCT00032188Phase 2
• Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00032110Phase 2
• Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the BrainCompletedNCT00032097Phase 1
• Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV MelanomaCompletedNCT00032045Phase 2
• Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the CervixCompletedNCT00031993Phase 2
• Mafosfamide in Treating Patients With Progressive or Refractory Meningeal TumorsCompletedNCT00031928Phase 1
• Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone SarcomaCompletedNCT00031915Phase 2
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Genetic Analysis of Brain TumorsTerminatedNCT00031538
• Vaccine Therapy in Treating Patients With Metastatic Solid TumorsTerminatedNCT00030693Phase 1
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of ChildhoodCompletedNCT00030667Phase 2
• Decitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00030615Phase 1
• Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00030537Phase 2
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial CancerCompletedNCT00030485Phase 2
• Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00030394Phase 2
• Iododoxorubicin in Treating Patients With Primary Systemic AmyloidosisTerminatedNCT00030381Phase 1
• Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00030368Phase 1
• Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic LeukemiaWithdrawnNCT00030355Phase 1/2
• 2-Methoxyestradiol in Treating Patients With Advanced Solid TumorsCompletedNCT00030095Phase 1
• Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver CancerCompletedNCT00030082Phase 1
• Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00029003Phase 2
• Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00028834Phase 2
• 2-Methoxyestradiol in Treating Patients With Advanced Solid TumorsCompletedNCT00028821Phase 1
• EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural CancerTerminatedNCT00028782Not applicable
• PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00028587Phase 1
• BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid TumorsTerminatedNCT00028561Phase 1
• Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid TumorsCompletedNCT00028535Phase 1
• R(+)XK469 in Treating Patients With Advanced NeuroblastomaCompletedNCT00028522Phase 1
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
• High-Risk Breast Duct EpitheliumCompletedNCT00028340
• CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00028028Phase 2
• Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00027898Phase 1
• Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00027872Phase 2
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant MesotheliomaCompletedNCT00027703Phase 2
• Gefitinib in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT00027690Phase 2
• APC8015 and Bevacizumab in Treating Patients With Prostate CancerCompletedNCT00027599Phase 2
• Effects of Raloxifene on Hormone LevelsCompletedNCT00026962Phase 2
• Study of Etoposide in Breast Cancer PatientsCompletedNCT00026949
• A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment PlanningCompletedNCT00026936Phase 2
• A Phase II Evaluation of Telesurgery SystemsCompletedNCT00026923Phase 2
• Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNCT00026910
• Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced CancerCompletedNCT00026897Phase 2
• Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification SystemCompletedNCT00026871Phase 1
• Total Body Irradiation for Bone Marrow Transplants: Collaborative EffortsCompletedNCT00026858Phase 2
• Long-Term Survival With HIV: Psychological and Behavioral Factors Associated With the Transition From Adolescence to Young AdulthoodCompletedNCT00026806
• Eligibility Screening for a NCI Pediatric Oncology Branch Research StudyCompletedNCT00026780
• Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant RecipientsCompletedNCT00026767
• Eligibility Screening for the NIH Intramural Research Program Clinical ProtocolsCompletedNCT00026754
• Research in Skin InflammationCompletedNCT00026741
• Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United StatesCompletedNCT00026728
• Evaluation for NCI Radiation Oncology Branch Clinical Research ProtocolsCompletedNCT00026689
• Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With DidanosineCompletedNCT00026676
• Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug ResistanceCompletedNCT00026663
• ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal CancerCompletedNCT00026364Phase 1
• Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT00026234Phase 2
• Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's LymphomaCompletedNCT00026182Phase 2
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney FailureCompletedNCT00026169Phase 1
• Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant MelanomaCompletedNCT00026143Phase 2
• Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT00026104Phase 2
• Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00026091Phase 2
• Biological Specimen Collection for Laboratory Methods Development and Training PurposesCompletedNCT00025831
• PS-341 in Treating Women With Metastatic Breast CancerCompletedNCT00025584Phase 2
• Thalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00025467Phase 2
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00025415Phase 1
• Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive RhabdomyosarcomaCompletedNCT00025363Phase 2
• Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously TreatedCompletedNCT00025337Phase 3
• Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During SurgeryCompletedNCT00025246Phase 2
• Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the UterusCompletedNCT00025220Phase 2
• Gefitinib in Treating Patients With Malignant MesotheliomaCompletedNCT00025207Phase 2
• Celecoxib in Preventing Skin CancerWithdrawnNCT00025051Phase 2
• Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic LeukemiaCompletedNCT00025038Phase 2
• Tenofovir Disoproxil Fumarate to Treat Pediatric HIVCompletedNCT00024986Phase 1
• B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA DeficiencyCompletedNCT00024934Phase 1
• SU6668 in Treating Patients With Advanced Solid TumorsCompletedNCT00024206Phase 1
• Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast CancerCompletedNCT00024154Phase 2
• BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWithdrawnNCT00024115Phase 1
• Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00024089Phase 2
• BMS-275291 in Treating Patients With HIV-Related Kaposi's SarcomaCompletedNCT00024024Phase 1/2

← National Cancer Institute (NCI) overview and focus areas